ArticleJournal of health, population, and nutrition2026
The association of triglyceride-glucose index and uric acid-high-density lipoprotein cholesterol ratio with the risk of uterine fibroids: a real-world analysis based on health examination data.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the association of triglyceride-glucose index (TyG) and uric acid to high-density lipoprotein cholesterol ratio (UHR) with the prevalence of uterine fibroids (UF), and to evaluate the dose-response relationship and differences in different subgroups.
methodsThis cross-sectional study employed real-world data from 40,529 adult female participants who underwent health examinations at Hebei Province Health Examination Center between January 1 and December 31, 2024. This study used multiple logistic regression analysis to determine the independent association between standardized TyG index, UHR, and UF risk. The dose-response relationship was evaluated with restricted cubic spline (RCS), and stratified analysis was conducted according to BMI, diabetes and menopause status.
resultsAmong 40,529 participants, the prevalence of UF was 29.8% (12,081 cases). The results of the fully adjusted model (Model 3) showed that both the standardized TyG index and UHR were significantly positively correlated with UF risk: for every 1 standard deviation (SD) increase in TyG, UF risk increased by 2.068 times (OR = 3.068); For every 1 SD increase in UHR, the risk increased by 11.7% (OR = 1.117). RCS analysis revealed that both the TyG index and UHR exhibited significant nonlinear associations with the risk of UF (P_overall < 0.001). Hierarchical analysis showed that TyG maintained significant correlation in all subgroups, while the effect of UHR was weakened in people with BMI ≥ 25 kg/m
conclusionElevated TyG index and UHR are significantly correlated with an increased prevalence risk of UF in women, and exhibit a non-linear dose-response relationship. The TyG index demonstrated a relatively significant association with UF risk, and the findings remained robust, supporting its utility as a simple indicator for capturing the relationship between metabolic abnormalities and UF risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.